Abstract:Taking advantage of cancer cells' endogenous characters, the responsive activation of DNA nanomachines has achieved great success in tumor therapy. Combining with extra stimuli such as external light irradiation provided spatiotemporal control of DNA nanomachine activation. However, specific activation at the cellular level is still challenging considering the macroscopic-scale exposure area of usual light sources. DNA logic gates located at the cell membrane contributed to cellular specificity, but the free diffusion of input DNA strands during the operation process would impair efficiency and result in side effects to circumjacent normal cells in solid tumors. Here we design a transmembrane DNA logical computation strategy to activate a DNA nanomachine only in cancer cells from a complex solid tumor microenvironment. The DNA nanomachine multishell UCNPs-DNA is prepared by modifying DNA strands on upconversion nanoparticles. LA-apt, a DNA strand anchoring to a cancer cell membrane overexpressed receptor, and intracellular miRNA-21 served as inputs 1 and 2, respectively. Hybridization with input 1 at the cell membrane not only exposes the miRNA-21 recognition region at the DNA nanomachine, but also delivers it into cancer cells. The cascade hybridization with intracellular input 2 completes the "AND" gate operation and releases a DNA strand L2 as output. L2 acts as the trigger to operate the DNA nanomachine and correspondingly activates the photosensitizer Rose Bengal for reactive oxygen species generation. Through the "AND" gate operation of the DNA nanomachine across the cancer cell membrane, highly precise therapy only to cancer cells is achieved in a complex solid tumor microenvironment, which could become a promising modality for precise therapy of solid tumors.

A logic-activated nanoswitch for killing cancer cells according to assessment of drug-resistance

Triplex DNA Nanoswitch for Ph-Sensitive Release of Multiple Cancer Drugs

DNA nanoswitches pack an anti-cancer punch

Site-specific nanoswitch circumventing immune resistance via activating TLR and inhibiting PD-L1/PD-1 axis

Logic-gated tumor-microenvironment nanoamplifier enables targeted delivery of CRISPR/Cas9 for multimodal cancer therapy

Metal-organic Frameworks Nanoswitch: Toward Photo-Controllable Endo/lysosomal Rupture and Release for Enhanced Cancer RNA Interference

An "AND" logic gate–based supramolecular therapeutic nanoplatform for combatting drug-resistant non–small cell lung cancer

Mechano‐Nanoswitches for Ultrasound‐Controlled Drug Activation

Activating a DNA Nanomachine Via Computation Across Cancer Cell Membranes for Precise Therapy of Solid Tumors.

DNA logic gate for cancer cells identification, detection, and modulation of cell–cell interactions

Nanomodified Switch Induced Precise and Moderate Activation of CAR‐T Cells for Solid Tumors (adv. Sci. 12/2023)

A transistor-like pH-sensitive nanodetergent for selective cancer therapy

MicroRNA-Responsive DNA-Programmed Nanomedicine with Controllability of Cascaded Events for Cancer Therapy Enhancement

Engineering Logic DNA Nanoprobes on Live Cell Membranes for Simultaneously Monitoring Extracellular pH and Precise Drug Delivery

CuS Nanoparticles As a Photodynamic Nanoswitch for Abrogating Bypass Signaling to Overcome Gefitinib Resistance.

A "dual-key-and-lock" DNA nanodevice enables spatially controlled multimodal imaging and combined cancer therapy

Tumor Cell Distinguishable Nanomedicine Integrating Chemotherapeutic Sensitization and Protection

Stimuli Responsive Nanoparticles for Controlled Anti-cancer Drug Release

A Programmed Nanoparticle with Self-Adapting for Accurate Cancer Cell Eradication and Therapeutic Self-Reporting.

Magnetically switchable mechano-chemotherapy for enhancing the death of tumour cells by overcoming drug-resistance

A Nanotheranostic System Combining Lysosomal Cell Death and Nuclear Apoptosis Functions for Synergistic Cancer Therapy and Addressing Drug Resistance